Search results
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Buy Rating from Chardan Capital
ETF DAILY NEWS· 4 days agoArrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “buy” rating reiterated by Chardan Capital in a research note issued on Monday ...
Crinetics Pharmaceuticals (NASDAQ:CRNX) Given “Buy” Rating at HC Wainwright
ETF DAILY NEWS· 5 days agoCrinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a note issued ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Raised by California State Teachers...
ETF DAILY NEWS· 6 days agoCalifornia State Teachers Retirement System lifted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.4% in the 4th quarter ...
Dimensional Fund Advisors LP Sells 84,895 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
ETF DAILY NEWS· 5 days agoDimensional Fund Advisors LP lowered its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 11.4% in the fourth quarter, according ...
Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT) By GuruFocus
Investing.com· 4 days agoInsider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
JMP Securities Reaffirms Market Outperform Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)
ETF DAILY NEWS· 5 days agoCrinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by analysts at JMP Securities in a report ...
Principal Financial Group Inc. Acquires 142 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
ETF DAILY NEWS· 6 days agoPrincipal Financial Group Inc. boosted its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 3.8% during the 4th quarter ...
Cyclacel Pharmaceuticals maintains $11 target, Buy rating By Investing.com
Investing.com· 5 days agoOn Monday, Roth/MKM maintained its Buy rating and $11.00 price target for Cyclacel Pharmaceuticals (...
A Quick Glance At Apellis Pharmaceuticals Inc (NASDAQ: APLS) Stock: It Is up 52.22% From Its 52-Week...
Marketing Sentinel· 3 days agoDuring the last session, Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s traded shares were 1.33 million, with the beta value of the company hitting 0.89. At ...
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP, Chief Regulatory & Quality ...
GuruFocus.com via Yahoo Finance· 5 days agoOn May 31, 2024, Ourania Tatsis, EVP, Chief Regulatory & Quality Officer of Vertex Pharmaceuticals...